Top Markets
Coin of the day
Defence Therapeutics Inc. Defence Therapeutics Inc.

Defence Therapeutics Inc.

DTC
Peringkat dalam Saham #28131
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Harga Saham
$0.37430781
Terakhir disinkronkan: 2026-08-19
Kapitalisasi Pasar
$28.37M
Perubahan (1 hari)
2.00%
Perubahan (1 tahun)
-13.46%
Negara
CA
Perdagangan Defence Therapeutics Inc. (DTC)

Kategori

Riwayat hasil dividen untuk Defence Therapeutics Inc. (DTC)
Hasil dividen (TTM) dari Defence Therapeutics Inc. (simbol saham: DTC) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Defence Therapeutics Inc. (DTC) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
0.00%
US
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH